Patents by Inventor Rolf Peter

Rolf Peter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (E)-N-(2-Amino-phenyl)-3--acrylamide salts
    Publication number: 20110086897
    Abstract: A salt of (E)-N-{2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-be?zenesulfonyl]-1H-pyrrol-3-yl)-acrylamide selected from the group consisting of the hydrobromide, methansulfonate, hemi ethane-1,2-disulfonate, benzenesulfonate, toiuenesulfonate and 2-naphthalenesulfonate.
    Type: Application
    Filed: March 11, 2009
    Publication date: April 14, 2011
    Applicant: 4SC AG
    Inventors: Jürgen Volz, Martin Feth, Rolf-Peter Hummel, Matthias Muller, Thomas Maier, Bernd Muller
  • APPARATUS AND METHOD FOR MEASURING LOCAL SURFACE TEMPERATURE OF SEMICONDUCTOR DEVICE
    Publication number: 20100322285
    Abstract: An apparatus and method is described for measuring a local surface temperature of a semiconductor device under stress. The apparatus includes a substrate, and a reference MOSFET. The reference MOSFET may be disposed closely adjacent to the semiconductor device under stress. A local surface temperature of the semiconductor device under stress may be measured using the reference MOSFET, which is not under stress. The local surface temperature of the semiconductor device under stress may be determined as a function of drain current values of the reference MOSFET measured before applying stress to the semiconductor device and while the semiconductor device is under stress.
    Type: Application
    Filed: August 26, 2010
    Publication date: December 23, 2010
    Inventor: Rolf-Peter Vollertsen
  • THERAPEUTIC AGENTS 927
    Publication number: 20100261733
    Abstract: (2S)-2-[1-(2-Chloro-6-cyano-phenyl)pyrazolo[4,5-e]pyrimidin-4-yl]oxy-3-[(1R)-2-hydroxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)propanamide or a pharmaceutically acceptable salt thereof is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
    Type: Application
    Filed: April 8, 2010
    Publication date: October 14, 2010
    Applicant: AstraZeneca AB
    Inventors: Stuart Norman Lile Bennett, Rolf Peter Walker, Michael James Waring
  • Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
    Patent number: 7811787
    Abstract: The invention relates to the identification and cloning of a two novel full-length human SLAP-2 variants and their encoded polypeptides, hSLAP-2v3 and hSLAP-2v4. hSLAP-2v3 and hSLAP-2v4 are members of the SLAP family of adapter proteins and are involved in the negative regulation of intracellular T-cell signal transduction. The invention further relates to the use of these novel hSLAP-2v3 and hSLAP-2v4 polynucleotides and their encoded polypeptides as targets for therapeutic intervention in immunological and inflammatory disorders, autoimmune diseases, pulmonary diseases, proliferative immune disorders, and cancer.
    Type: Grant
    Filed: April 24, 2007
    Date of Patent: October 12, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Donald G. Jackson, Stanley R. Krystek, Jr., Donna A. Bassolino, Rolf-Peter Ryseck, Thomas C. Nelson, Gena S. Whitney
  • Apparatus and method for measuring local surface temperature of semiconductor device
    Patent number: 7798703
    Abstract: An apparatus and method is described for measuring a local surface temperature of a semiconductor device under stress. The apparatus includes a substrate, and a reference MOSFET. The reference MOSFET may be disposed closely adjacent to the semiconductor device under stress. A local surface temperature of the semiconductor device under stress may be measured using the reference MOSFET, which is not under stress. The local surface temperature of the semiconductor device under stress may be determined as a function of drain current values of the reference MOSFET measured before applying stress to the semiconductor device and while the semiconductor device is under stress.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: September 21, 2010
    Assignee: Infineon Technologies AG
    Inventor: Rolf-Peter Vollertsen
  • Novel salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
    Publication number: 20100190818
    Abstract: The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical composition for use, e.g., in treatment of airway disorders.
    Type: Application
    Filed: March 26, 2010
    Publication date: July 29, 2010
    Applicant: Nycomed GmbH
    Inventors: Ulrich Kautz, Matthias Webel, Christian Scheufler, Rolf-Peter Hummel
  • Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
    Patent number: 7718668
    Abstract: The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4-inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions for use, e.g., in treatment of airway disorders.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: May 18, 2010
    Assignee: Nycomed GmbH
    Inventors: Ulrich Kautz, Matthias Webel, Christian Scheufler, Rolf-Peter Hummel
  • Amorphous ciclesonide
    Publication number: 20100120737
    Abstract: The present invention relates to amorphous ciclesonide, methods to prepare the same, pharmaceutical compositions comprising amorphous ciclesonide as active ingredient, and methods of treatment using amorphous ciclesonide.
    Type: Application
    Filed: November 10, 2008
    Publication date: May 13, 2010
    Inventors: Martin Feth, Rolf-Peter Hummel, Jurgen Volz, Peter Zimmermann, Beate Schmidt
  • PYRAZOLONE DERIVATIVES AS PDE4 INHIBITORS
    Publication number: 20100120757
    Abstract: The compounds of a certain formula 1, in which R1, R7, R8, R9 and n have the meanings as given in the description, are novel effective inhibitors of the type 4 phosphodiesterase.
    Type: Application
    Filed: May 14, 2008
    Publication date: May 13, 2010
    Applicant: NYCOMED GmbH
    Inventors: Beate Schmidt, Christian Scheufler, Juergen Volz, Martin Feth, Rolf-Peter Hummel, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Deborah Ockert, Anke Heuser, Johannes A.M. Christiaans, Geert Jan Sterk, Wiro M.P.B. Menge
  • Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23
    Patent number: 7713699
    Abstract: The present invention provides novel polynucleotides encoding HGPRBMY23 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY23 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly renal diseases and/or disorders, colon cancer, breast cancer, and diseases and disorders related to aberrant NFKB modulation. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: May 11, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: John N. Feder, Thomas C. Nelson, Chandra S. Ramanathan, Rolf-Peter Ryseck, Michael G. Kornacker
  • THERAPEUTIC AGENTS 414
    Publication number: 20100093757
    Abstract: A compound of Formula (I): is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
    Type: Application
    Filed: August 4, 2009
    Publication date: April 15, 2010
    Applicant: AstraZeneca AB
    Inventors: Stuart Norman Lile BENNETT, Roger John Butlin, Leonie Campbell, Robert Darren Morse Davies, Graeme Richard Robb, Rolf Peter Walker, Michael James Waring, Helen Claire Pointon, Mikael Dan Brink, Jonas Rickard Fägerhag, Ulrik Jurva, Volker Schnecke, Anette Marie Svensson Henriksson, Christer Ralf Westerlund, Peter Gustaf Bonn
  • STRUCTURED SEMICONDUCTOR ELEMENT FOR REDUCING CHARGING EFFECTS
    Publication number: 20100019398
    Abstract: A semiconductor circuit element for reducing undesirable charging effects for a connection element of test structures for semiconductor circuits is disclosed. A surface of a semiconductor circuit element has interconnect structures that are electrically insulated from the remainder of the surface of the semiconductor circuit element, where exclusively the interconnect structures are connected to semiconductor circuit elements arranged downstream.
    Type: Application
    Filed: October 7, 2009
    Publication date: January 28, 2010
    Inventor: Rolf-Peter Vollertsen
  • Structured semiconductor element for reducing charging effects
    Patent number: 7646104
    Abstract: A semiconductor circuit element for reducing undesirable charging effects for a connection element of test structures for semiconductor circuits is disclosed. A surface of a semiconductor circuit element has interconnect structures that are electrically insulated from the remainder of the surface of the semiconductor circuit element, where exclusively the interconnect structures are connected to semiconductor circuit elements arranged downstream.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: January 12, 2010
    Assignee: Infineon Technologies A.G.
    Inventor: Rolf-Peter Vollertsen
  • Sulphonylpyrrole Hydrochloride Salts as Histone Deacetylases Inhibitors
    Publication number: 20090297473
    Abstract: Compounds of a certain formula 1, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors.
    Type: Application
    Filed: September 8, 2006
    Publication date: December 3, 2009
    Applicant: Nycomed GmbH
    Inventors: Thomas Maier, Thomas Beckers, Rolf-Peter Hummel, Martin Feth, Matthias Müller, Thomas Bär
  • Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
    Publication number: 20090263353
    Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors.
    Type: Application
    Filed: September 8, 2006
    Publication date: October 22, 2009
    Applicant: Nycomed GmbH
    Inventors: Thomas Maier, Thomas Beckers, Rolf-Peter Hummel, Martin Feth, Matthias Muller, Thomas Bar, Jurgen Volz
  • Novel benzonaphthyridines
    Publication number: 20090030029
    Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.
    Type: Application
    Filed: September 23, 2008
    Publication date: January 29, 2009
    Applicant: Altana Pharma AG
    Inventors: Dieter Flockerzi, Rolf-Peter Hummel, Felix Reutter
  • Vehicle seat and cabriolet vehicle with such a vehicle seat
    Patent number: 7478874
    Abstract: A vehicle seat, in particular functioning as a rear vehicle seat having a seat element provided at the free end of the backrest, and a vehicle with such a seat are specified in which the seat element is pivotably linked to a backrest structure of the vehicle seat and the seat element acts at the same time as a headrest and as protection against rollover.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: January 20, 2009
    Assignee: Wilhelm Karmann GmbH
    Inventors: Hanno Figenser, Rolf-Peter Baule
  • Mail Processing System and Method of Loading Articles with Reduced Speed
    Publication number: 20090012645
    Abstract: A mail processing system has an infeed line coupled to receive a first article from a feeder. A loading device is coupled to receive the first article from the infeed line at a first speed, and a transfer unit is coupled to receive the first article from the loading device, wherein the transfer unit is configured to transport the first article at a second speed, which is lower than the first speed.
    Type: Application
    Filed: October 31, 2005
    Publication date: January 8, 2009
    Applicant: Siemens Aktiengesellschaft
    Inventors: Bertram Wanner, Rolf-Peter Skrdlant
  • Benzonaphthyridines
    Patent number: 7470704
    Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: December 30, 2008
    Assignee: Nycomed GmbH
    Inventors: Dieter Flockerzi, Rolf-Peter Hummel, Felix Reutter
  • APPARATUS AND METHOD FOR MEASURING LOCAL SURFACE TEMPERATURE OF SEMICONDUCTOR DEVICE
    Publication number: 20080279252
    Abstract: An apparatus and method is described for measuring a local surface temperature of a semiconductor device under stress. The apparatus includes a substrate, and a reference MOSFET. The reference MOSFET may be disposed closely adjacent to the semiconductor device under stress. A local surface temperature of the semiconductor device under stress may be measured using the reference MOSFET, which is not under stress. The local surface temperature of the semiconductor device under stress may be determined as a function of drain current values of the reference MOSFET measured before applying stress to the semiconductor device and while the semiconductor device is under stress.
    Type: Application
    Filed: May 9, 2007
    Publication date: November 13, 2008
    Applicant: INFINEON TECHNOLOGIES AG
    Inventor: Rolf-Peter Vollertsen